PRDS DATA 联系方式: t.me/PRDSdata 页头:登录 | 页头:注册

Bruker Corporation(NASDAQ:BRKR)

{{price.price}} USD
{{price.change}}%
最高:{{price.high}} 成交量:3337883 市销率:2.59% 每股收益(TTM):2.0768
最低:{{price.low}} 成交额:190259331 市盈率(TTM):27.45% 52周最高:94
今开:{{price.open}} 振幅:3.09% 净利率:9.41% 52周最低:48
昨收:{{price.close}} 一天跳空:0.07 毛利率:1598400000% 总市值:8641099457
买盘
卖盘
分时成交
1周表现 -2.68 1月表现 12.6 3月表现 -16.5 6月表现 -14.53
YTD表现 -21.6 1年表现 -22.65 5年表现 13.48 10年表现 189.78
1天波动率 5.1 1周波动率 3.86 1月波动率 3.8 成交量 3337883
1周成交量 10282570 1月成交量 21421892 符号详情:1天涨跌率 3.09 1周涨跌率 -1.26
1月涨跌率 -1.64 1天涨跌 1 1周涨跌 0 1月涨跌 0
今开 55 1周开盘价 56 1月开盘价 57 10天平均成交量 1574570.5
30天平均成交量 1569538.73 60天平均成交量 1433974.68 90天平均成交量 1314661.81 相对成交量 1.45
一天跳空 0.07 一周跳空 -1.82 一月跳空 -0.93 1天相对成交量 2.47
1周相对成交量 1.47 1月相对成交量 0.88 1月最低低点 52 3月最低低点 48
6月最低低点 48 全部最低低点 2 52周最低 48 1月最高高点 61
3月最高高点 72 6月最高高点 72 全部最高高点 94 52周最高 94
基本每股收益(年度) 2.92 基本每股收益(TTM) 2.08 净收入(年度) 427200000 净收入(TTM) 304900000
毛利率(季度) 420000000 毛利率(年度) 1516800000 毛利率(TTM) 1598400000 每股收益预期(季度) 0.74
摊薄每股收益(季度) 0.27 摊薄每股收益(年度) 2.9 摊薄每股收益(TTM) 2.08 营销收入(TTM) 377700000
收入(年度) 2964500000 收入(TTM) 3241300000 融资CF(TTM) 1246400000 经营CF(TTM) 266800000
投资CF(TTM) -1735000000 资本支出(TTM) -110100000 自由现金流(TTM) 156700000 自由现金流(年度) 243200000
自由现金流(季度) 5800000 净债务(季度) 2269700000 权益总额(季度) 1843100000 商誉(季度) 1474600000
现金等价物(季度) 148100000 现金等价物(年度) 488300000 手头现金(季度) 148100000 手头现金(季度) 488300000
总负债(季度) 2191400000 总负债(年度) 2836600000 流动负债(季度) 1322100000 流动资产(季度) 1322100000
总债务(季度) 2417800000 总资产(季度) 6112900000 企业价值 10946899457 价格现金比 58.5
市场表现(1周) 0 市场表现(1个月) 0 市场表现(3个月) 0 市场表现(6个月) 0
市场表现(今年至今) 0 市场表现(1年) 0 市场表现(5年) 0 净利率(年度) 14.41
净利率(TTM) 9.41 毛利率(年度) 51.17 毛利率(TTM) 49.31 股本回报率(年度) 34.3
股本回报率(TTM) 20.22 经营利润率(年度) 16.27 经营利润率(TTM) 11.65
简介
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment includes life science tools based on magnetic resonance technology. The BSI CALID segment focuses on life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions based on infrared and Raman molecular spectroscopy technologies and radiological and nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The BSI Nano segment offers advanced x-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, analytical tools for electron microscopes and x-ray metrology, defect-detection equipment for semiconductor process control, handheld, portable, and mobile x-ray fluorescence spectrometry instruments, spark optical emission spectroscopy systems, and chip cytometry products and services for targeted spatial proteomics, multi-omics services, and products and services for spatial genomics research. The BEST segment is involved in superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research. The company was founded by Emil Bruker and Günther Laukien in 1960 and is headquartered in Billerica, MA.

公司网站 : http://www.bruker.com

总经理:Frank H. Laukien

建立时间:1960

公司总部:Billerica

领域:Health technology

行业:Medical specialties